- Home
- TPST vs CIF Comparison
TPST vs CIF Comparison
Compare TPST & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPST
- CIF
- Stock Information
- Founded
- TPST 2011
- CIF 1988
- Country
- TPST United States
- CIF United States
- Employees
- TPST N/A
- CIF N/A
- Industry
- TPST Biotechnology: Pharmaceutical Preparations
- CIF Trusts Except Educational Religious and Charitable
- Sector
- TPST Health Care
- CIF Finance
- Exchange
- TPST Nasdaq
- CIF Nasdaq
- Market Cap
- TPST 33.0M
- CIF 30.8M
- IPO Year
- TPST N/A
- CIF N/A
- Fundamental
- Price
- TPST $7.76
- CIF $1.75
- Analyst Decision
- TPST Hold
- CIF
- Analyst Count
- TPST 3
- CIF 0
- Target Price
- TPST $30.00
- CIF N/A
- AVG Volume (30 Days)
- TPST 80.4K
- CIF 43.9K
- Earning Date
- TPST 08-07-2025
- CIF 01-01-0001
- Dividend Yield
- TPST N/A
- CIF 10.11%
- EPS Growth
- TPST N/A
- CIF N/A
- EPS
- TPST N/A
- CIF N/A
- Revenue
- TPST N/A
- CIF N/A
- Revenue This Year
- TPST N/A
- CIF N/A
- Revenue Next Year
- TPST N/A
- CIF N/A
- P/E Ratio
- TPST N/A
- CIF N/A
- Revenue Growth
- TPST N/A
- CIF N/A
- 52 Week Low
- TPST $5.35
- CIF $1.47
- 52 Week High
- TPST $28.34
- CIF $1.77
- Technical
- Relative Strength Index (RSI)
- TPST 63.65
- CIF 55.66
- Support Level
- TPST $6.11
- CIF $1.72
- Resistance Level
- TPST $6.49
- CIF $1.76
- Average True Range (ATR)
- TPST 0.35
- CIF 0.02
- MACD
- TPST 0.03
- CIF -0.00
- Stochastic Oscillator
- TPST 100.00
- CIF 50.00
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.